The digital health solutions that Allianz X and American Well develop will build on American Well’s platform and leverage Allianz’s international expertise. The solutions will combine wearable sensors, remote monitoring and virtual visits.
The partnership will work with local healthcare stakeholders to deliver healthcare solutions to both developed and emerging markets.
Allianz X led the investment, with Health Innovation Center of Allianz Partners, the business-to-business-to-customer unit of the Allianz Group, supporting the investment. Allianz has a qualified network of more than 800,000 medical providers around the globe.
“Allianz X’s investment with American Well will result in better access, lower cost and more connected care for our customers through a leading-edge health platform. This collaboration emphasizes Allianz’s commitment to digitalization, our goal of investing in digital frontrunners and encourages advancements within the whole healthcare ecosystem,” said Solmaz Altin, chief digital officer of Allianz Group.
More articles on telehealth:
FCC proposes rule to lift $400M funding cap on rural telehealth program
Rutgers University rolls out telemedicine for kids’ mental health
Study: ‘Door-to-needle’ time drops 20 minutes with telestroke
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
